Skip to main content
. 2023 Apr 11;24(1):39. doi: 10.1186/s10194-023-01573-6

Fig. 3.

Fig. 3

Risk of bias ratings. Two out of three trials and one out of two trials were at high risk of bias due to missing outcome data for 50% or more reduction in monthly migraine days and adverse events leading to discontinuation, respectively. One trial, reporting on monthly migraine days, was at low risk of bias